Lexaria Bioscience Corp. ( LEXX) - Stock Earnings
LEXX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 28, 2026, midnight | — / — | — | — / — | — |
LEXX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -649539 USD | 145000 USD |
| 2024Q4 | -2.7 million USD | 174000 USD |
| 2025Q4 | -1.4 million USD | 20000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
LEXX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -6.7 million USD | 226208 USD |
| 2024 | -5.8 million USD | 464278 USD |
| 2025 | -11.9 million USD | 705923 USD |
| 2026 Est. | — | — |
LEXX
Price: $3.42
52 week price:
Earnings Per Share: -0.34 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 7400
Market Capitalization: 4.6 million